tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
SCYNEXIS (SCYX)
NASDAQ:SCYX
US Market
SCYX
SCYNEXIS
RESEARCH TOOLSreports

SCYNEXIS (SCYX) Stock News & Sentiment

Compare
1,560 Followers
SCYNEXIS Halts Phase 3 MARIO Trial, Raising New Questions for Ibrexafungerp’s Growth Path
Premium
Company Announcements
SCYNEXIS Halts Phase 3 MARIO Trial, Raising New Questions for Ibrexafungerp’s Growth Path
1M ago
SCYX
SCYNEXIS: Strong Financial Position and Promising Antifungal Pipeline Drive Buy Rating
Premium
Ratings
SCYNEXIS: Strong Financial Position and Promising Antifungal Pipeline Drive Buy Rating
3M ago
SCYX
SCYNEXIS Reports Q3 2025 Financial Results and Strategic Updates
Premium
Company Announcements
SCYNEXIS Reports Q3 2025 Financial Results and Strategic Updates
3M ago
SCYX
SCYX Upcoming Earnings Report: What to Expect?
Premium
Pre-Earnings
SCYX Upcoming Earnings Report: What to Expect?
3M ago
SCYX
SCYNEXIS: Strategic Advancements and Financial Stability Drive Buy Rating
Premium
Ratings
SCYNEXIS: Strategic Advancements and Financial Stability Drive Buy Rating
4M ago
SCYX
SCYNEXIS and GSK Amend License Agreement
Premium
Company Announcements
SCYNEXIS and GSK Amend License Agreement
4M ago
8K
SCYX
Buy Rating on SCYNEXIS: Promising Potential of SCY-247 Amid Market Volatility
Premium
Ratings
Buy Rating on SCYNEXIS: Promising Potential of SCY-247 Amid Market Volatility
4M ago
SCYX
More SCYX News >

SCYX News on the Web

Scynexis announces presentation highlighting data from SCY-247
TipRanks News
Bullish
Scynexis (SCYX) Gains FDA Designations for Antifungal Therapy SCY-247
GuruFocus News
Bullish
SCYNEXIS Completes BREXAFEMME NDA Transfer to GSK—Milestone Payments Could Reach $145.5 Million
Market Chameleon
Neutral
VTYX, MEDP, INBX Jump After Hours On Key Updates
rttnews
Neutral
SCYNEXIS Secures $22 Million from GSK Agreement—Cash Runway Now Extended Over Two Years
Market Chameleon
Neutral
SCYNEXIS Begins Phase 1 Trial Of SCY-247 For Severe Invasive Fungal Infections
rttnews
Neutral
Analysts Offer Insights on Healthcare Companies: Hookipa Pharma (HOOK) and SCYNEXIS (SCYX)
TipRanks News
Bullish
SCYNEXIS’s Strong Financial Position and Strategic Advancements Drive Buy Rating
TipRanks News
Bullish

News Score - Last 7 Days

Neutral
SCYX
Sector Average
Media Buzz
This Week1 articles
Weekly Average1 articles
News Sentiment
This Week100%
Sector Average73%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is SCYX’s Media Buzz Sentiment?
1 articles about SCYX were published this week. In an average week, 1 articles are published.
    What is SCYX’s weekly average amount of articles?
    In an average week, 1 articles about SCYX are published.
      What is SCYX’s News Sentiment?
      100% of articles about SCYX were positive this week, compared to its sector average of 73%.
        Healthcare Stocks that are Trending in the News
        IMAImageneBio
        HOCPFHOYA
        CBLControl Bionics Ltd.
        CRDFCardiff Oncology
        QNCXQuince Therapeutics
        Showing the stocks with the most bullish news sentiment over the past week